Generation Bio Cash Flow from Operating Activities 2020-2023 | GBIO
Generation Bio cash flow from operating activities from 2020 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
| Generation Bio Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2023 | $-53 |
| 2022 | $-102 |
| 2021 | $-92 |
| 2020 | $-70 |
| 2019 | $-40 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.189B | $0.006B |
| Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $18.924B | 6.59 |
| Dr Reddy's Laboratories (RDY) | India | $11.661B | 17.34 |
| Aspen Pharmacare (APNHY) | South Africa | $5.609B | 0.00 |
| BridgeBio Pharma (BBIO) | United States | $5.333B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $2.615B | 1.99 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.072B | 12.46 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.632B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.449B | 0.00 |
| Personalis (PSNL) | United States | $0.080B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.074B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.026B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.019B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |